Notably, artesunate has shown efficacy in breast cancer through glutathione peroxidase 4 (GPX4) inhibition, resulting in increased intracellular reactive oxygen species (ROS) and lipid peroxidation [11]. Here, GPX4 is linked to breast cancer.